← Frontpage

Protein Goes Probiotic, and Heads to Walmart

2h ago · 4 sources · funding

Rogue just raised $2.5m and wasted no time putting it to work. The Science Inc.-backed snack brand is rolling out to 2,800 Walmart stores nationwide in July, a massive gate for any young company.

Rogue comes from the team behind Dollar Shave Club and Liquid Death, and it shows. The pitch is not just protein. It is protein with personality. Four SKUs, including Spicy Chicken Sandwich Chips and Churro Puffs, pack up to 20g of protein plus active probiotics. No seed oils. No artificial ingredients. The brand says consumers should not have to choose between taste and function.

The timing makes sense. US protein snacks are projected to hit $1.8bn in 2025, growing 8%-9% annually over the next decade. That is real momentum. Rogue is betting it can skip the slow grind by pairing a digital-first strategy with instant national scale at Walmart.

The bigger takeaway: the old playbook was win shelf, then build brand. Rogue is trying to do both at once. Big retail footprint. Influencer-driven digital commerce. Function stacked on function. Protein is no longer enough. Now it needs probiotics and a point of view.

Key facts

  • Protein snack brand Rogue has raised $2.5m to accelerate a national retail expansion.
  • Rogue is set to roll out nationally across the US in 2,800 Walmart stores in July.
  • Rogue was developed in-house by Science Inc, the LA-based startup studio behind Dollar Shave Club and Liquid Death.
  • The four SKUs contain up to 20g of protein and active probiotics, and are made without seed oils or artificial ingredients.
  • US demand for protein snacks is projected to reach approximately $1.8bn in 2025 and grow at an annual rate of roughly 8%-9% over the next decade.
  • Armed with $2.5 million in pre-seed funding, Rogue is gearing up for its retail debut in 2,800 Walmart stores nationwide.
  • The $2.5 million pre-seed round was led by Science Inc. with participation from Uncommon VC and Simple Food Ventures.
  • $2.5m
  • 2,800
  • 20g
  • $1.8bn
  • 8%-9%

Coverage